Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...

Drugmaker Novo Nordisk says it will make the popular weight GLP-1 weight loss medication Wegovy more affordable for those ...

Dishing out some much-needed inspiration, a woman named Jahnavi shared her amazing weight loss journey through a video ...

Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...

Now, it’s worth noting Stock Advisor’s total average return is 1,035% — a market-crushing outperformance compared to 191 % ...

The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s ...

LifeMD expands access to Wegovy and Ozempic at the lowest cash-pay pricing, reinforcing its commitment to patient affordability and high-quality care ...

The medications have grown popular for weight loss, but one doctor has found another use: combating alcohol and drug ...